Email Newsletters

Life Sciences

RXi Q2 Loss Reaches $5M

Worcester-based RXi Pharmaceuticals Corp. reported a $5.1 million loss for the second quarter compared to a loss...

MIT Researchers Create Cancer Stem Cells

Researchers at the Massachusetts Institute of Technology have created "queen" cancer stem cells they say could significantly...

Biotech Startups Turn To Big Pharma For Survival

 Money for startup biotechs sure is hard to come by in this economy. And that means more...

Maynard Firm Keeps To Its Primary Mission

Alfred Chi has a big vision for his small company, CHI Scientific of Maynard. In September,...
ADVERTISEMENT

GTC Losses Mount, Cash Dwindles

GTC Biotherapeutics Inc. lost $10.8 million during the second quarter, but said it had taken steps to...

RXi Plans $7.8M Share Offering

Worcester-based RXi Pharmaceuticals Corp. is offering 2.4 million shares of its common stock for sale to the...

WPI, CellThera Researchers Turn On Stem Cells

A team of researchers at Worcester Polytechnic Institute's Life Sciences and Bioengineering Center at Gateway Park in...

Do-It-Yourself RNAi Tech

Worcester's RXi Pharmaceuticals Corp. has acquired an exclusive license to technology that could allow patients to administer...
ADVERTISEMENT

Q2 Profit Gains For Genzyme

Genzyme Corp. reported a second quarter profit of $192 million on a 5 percent revenue increase and...

Troubled ACT Reports Loss, Seeks Re-listing

Worcester's Advanced Cell Technology reported a first quarter loss of $19 million, compared to a $9.5 million...
ADVERTISEMENT

Latest Stories

More Business News
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

More Jobs | Submit a Job
More Events | Submit an Event

December Flash Sale! Get 40% off new subscriptions from now until December 19th!

Close the CTA

Get our email newsletter

Stay up-to-date on the companies, people and issues that impact businesses in Central Massachusetts.

Close the CTA